Synonym
Lysine 4-nitroanilide
IUPAC/Chemical Name
Hexanamide, 2,6-diamino-N-(4-nitrophenyl)-
InChi Key
VUUNELJIFNFWJC-UHFFFAOYSA-N
InChi Code
InChI=1S/C12H18N4O3/c13-8-2-1-3-11(14)12(17)15-9-4-6-10(7-5-9)16(18)19/h4-7,11H,1-3,8,13-14H2,(H,15,17)
SMILES Code
O=C(NC1=CC=C([N+]([O-])=O)C=C1)C(N)CCCCN
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
266.30
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Sousa MO, Miranda TL, Maia CN, Bittar ER, Santoro MM, Figueiredo AF. Kinetic peculiarities of human tissue kallikrein: 1--substrate activation in the catalyzed hydrolysis of H-D-valyl-L-leucyl-L-arginine 4-nitroanilide and H-D-valyl-L-leucyl-L-lysine 4-nitroanilide; 2--substrate inhibition in the catalyzed hydrolysis of N alpha-p-tosyl-L-arginine methyl ester. Arch Biochem Biophys. 2002 Apr 1;400(1):7-14. PubMed PMID: 11913965.
2: Stepanov VM, Terent'eva EYu, Voyushina TL, Gololobov MYu. Subtilisin and alpha-chymotrypsin catalyzed synthesis of peptides containing arginine and lysine p-nitroanilides as C-terminal moieties. Bioorg Med Chem. 1995 May;3(5):479-85. PubMed PMID: 7648197.
3: Blanc B, Laloi P, Atlan D, Gilbert C, Portalier R. Two cell-wall-associated aminopeptidases from Lactobacillus helveticus and the purification and characterization of APII from strain ITGL1. J Gen Microbiol. 1993 Jul;139(7):1441-8. PubMed PMID: 8371107.
4: Arbesú MJ, Valle E, Suárez-Rendueles P. Purification and characterization of aminopeptidase yspI from Schizosaccharomyces pombe. Yeast. 1993 Jun;9(6):637-44. PubMed PMID: 8346680.
5: Cowman RA, Baron SS. Studies on the subcellular localization of protease and arylaminopeptidase activities in Streptococcus sanguis ATCC 10556. J Dent Res. 1991 Dec;70(12):1508-15. PubMed PMID: 1774382.
6: Petersen LC, Brender J, Suenson E. Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation. Biochem J. 1985 Jan 1;225(1):149-58. PubMed PMID: 2579638; PubMed Central PMCID: PMC1144563.
7: Petersen LC, Clemmensen I. Kinetics of plasmin inhibition in the presence of a synthetic tripeptide substrate. The reaction with pancreatic trypsin inhibitor and two forms of alpha 2-plasmin inhibitor. Biochem J. 1981 Oct 1;199(1):121-7. PubMed PMID: 6175313; PubMed Central PMCID: PMC1163341.
8: Eggimann B, Bachmann M. Purification and Partial Characterization of an Aminopeptidase from Lactobacillus lactis. Appl Environ Microbiol. 1980 Nov;40(5):876-82. PubMed PMID: 16345655; PubMed Central PMCID: PMC291682.
9: Papke G, Blobel H. [Qualitative and quantitative determinations of staphylokinase-activity (author's transl)]. Zentralbl Bakteriol Orig A. 1978 Dec;242(4):456-61. German. PubMed PMID: 219637.
10: Bury AF, Coolbear T, Savery CR. Separation and properties of two arylamidases from rat cardiac-muscle extracts. Biochem J. 1977 Jun 1;163(3):565-70. PubMed PMID: 406901; PubMed Central PMCID: PMC1164737.
